Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $857.80 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $117.87 | 5 | $0 (2023) |
| Biocompatibles, Inc. | $92.02 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $90.16 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $58.56 | 3 | $0 (2024) |
| Seagen Inc. | $55.27 | 3 | $0 (2023) |
| Incyte Corporation | $53.29 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $50.21 | 2 | $0 (2023) |
| Amgen Inc. | $47.49 | 3 | $0 (2021) |
| GENZYME CORPORATION | $44.25 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $42.02 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.68 | 6 | GENZYME CORPORATION ($44.25) |
| 2023 | $100.21 | 4 | Bayer Healthcare Pharmaceuticals Inc. ($26.91) |
| 2022 | $305.73 | 15 | AstraZeneca Pharmaceuticals LP ($94.07) |
| 2021 | $174.99 | 10 | Alexion Pharmaceuticals, Inc. ($42.02) |
| 2020 | $51.66 | 3 | Seagen Inc. ($20.04) |
| 2018 | $107.53 | 2 | Biocompatibles, Inc. ($92.02) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Oncology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Hematology/Oncology | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Oncology | ||||||
| 01/30/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Oncology | ||||||
| 04/28/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.80 | General |
| 04/25/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Oncology | ||||||
| 02/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Oncology | ||||||
| 01/03/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Oncology | ||||||
| 12/07/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Oncology | ||||||
| 10/28/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Oncology | ||||||
| 10/11/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.81 | General |
| 09/13/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Oncology | ||||||
| 05/25/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Oncology | ||||||
| 03/29/2022 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Oncology | ||||||
| 03/18/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 96 | 171 | $99,324 | $34,877 |
| 2020 | 9 | 156 | 227 | $361,303 | $59,988 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2021 | 12 | 12 | $70,064 | $23,158 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 72 | $10,152 | $4,169 | 41.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 30 | $5,304 | $2,496 | 47.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 21 | 27 | $4,482 | $1,964 | 43.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $4,369 | $1,781 | 40.8% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Facility | 2021 | 13 | 13 | $4,953 | $1,308 | 26.4% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 23 | 23 | $257,483 | $45,692 | 17.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 33 | 85 | $17,087 | $4,625 | 27.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 36 | $11,210 | $3,072 | 27.4% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2020 | 15 | 15 | $43,403 | $1,713 | 3.9% |
| 50327 | Preparation of donor kidney for transplantation | Facility | 2020 | 15 | 15 | $15,732 | $1,438 | 9.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $4,328 | $955.39 | 22.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 12 | 15 | $3,640 | $887.43 | 24.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 15 | $3,951 | $803.99 | 20.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $4,469 | $801.52 | 17.9% |
About Mark Johnson
Mark Johnson is a Transplant Surgery healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649313909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Johnson has received a total of $857.80 in payments from pharmaceutical and medical device companies, with $117.68 received in 2024. These payments were reported across 40 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($857.80).
As a Medicare-enrolled provider, Johnson has provided services to 252 Medicare beneficiaries, totaling 398 services with total Medicare billing of $94,865. Data is available for 2 years (2020–2021), covering 15 distinct procedure/service records.
Practice Information
- Specialty Transplant Surgery
- Other Specialties Surgery
- Location Atlanta, GA
- Active Since 02/15/2007
- Last Updated 07/10/2015
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1649313909
Products in Payments
- THERASPHERE - BIO (Device) $92.02
- IMFINZI (Biological) $70.26
- KEYTRUDA (Biological) $58.56
- Nubeqa (Drug) $50.21
- SARCLISA (Biological) $44.25
- Ultomiris (Drug) $42.02
- MEKINIST (Drug) $38.90
- ADCETRIS (Biological) $35.23
- ACTHAR (Biological) $34.75
- Doptelet (Drug) $31.53
- JAKAFI (Drug) $29.59
- PIQRAY (Drug) $26.26
- PROMACTA (Drug) $25.00
- MONJUVI (Drug) $23.70
- LIVTENCITY (Drug) $23.55
- TUKYSA (Drug) $20.04
- ZEJULA (Drug) $18.80
- XOSPATA (Drug) $18.20
- Orserdu (Drug) $17.65
- NINLARO (Drug) $17.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in Atlanta
Dr. Roshan Shrestha, Md, MD
Transplant Surgery — Payments: $477,841
Dr. Nicole Turgeon, M.d, M.D
Transplant Surgery — Payments: $89,786
Stuart Knechtle, Md, MD
Transplant Surgery — Payments: $89,085
Allan Kirk, Md, MD
Transplant Surgery — Payments: $66,628
Andrew Adams, Md, Phd, MD, PHD
Transplant Surgery — Payments: $63,762
Marty Sellers, Md Mph, MD MPH
Transplant Surgery — Payments: $49,106